Viral retinitis: diagnosis and management in the era of biologic immunosuppression: A review.

Epstein-Barr virus acute retinal necrosis cytomegalovirus retinitis progressive outer retinal necrosis

Journal

Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531

Informations de publication

Date de publication:
04 2019
Historique:
received: 18 10 2018
revised: 08 02 2019
accepted: 18 02 2019
pubmed: 13 3 2019
medline: 10 5 2020
entrez: 13 3 2019
Statut: ppublish

Résumé

Necrotising retinitis is a rare ocular infection that historically led to high rates of visual morbidity. While acute retinal necrosis occurs in immunocompetent patients, the majority of cases are associated with immunocompromise such as in cytomegalovirus retinitis and progressive outer retinal necrosis. This review summarises the clinical and diagnostic features, management, and outcomes of herpetic retinitis. Iatrogenic immunosuppression is increasingly being utilised for a wide range of indications, and biologic agents especially so due to their targeted nature. While the intended actions are well-studied, the flow-on effects and complex interaction with host immunity are not well understood. Furthermore, biologics are frequently used concomitantly with other immunosuppressive agents, potentiating the immunodepression. This article reviews the literature on biologic immunosuppression and viral retinitis, and presents an approach to the vulnerable or affected patient. Early identification, prompt and aggressive treatment, and a multidisciplinary approach to managing immunodeficiency are the cornerstones of management.

Identifiants

pubmed: 30859706
doi: 10.1111/ceo.13500
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-395

Informations de copyright

© 2019 Royal Australian and New Zealand College of Ophthalmologists.

Auteurs

Xia Ni Wu (XN)

Ophthalmology, Moorfields Eye Hospital, London, UK.
Faculty of Brain Sciences, Institute of Ophthalmology, London, UK.

Sue Lightman (S)

Ophthalmology, Moorfields Eye Hospital, London, UK.
Faculty of Brain Sciences, Institute of Ophthalmology, London, UK.

Oren Tomkins-Netzer (O)

Ophthalmology, Moorfields Eye Hospital, London, UK.
Faculty of Brain Sciences, Institute of Ophthalmology, London, UK.
Department of Ophthalmology, Bnai Zion Medical Centre, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH